secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
CIK:        0001742927
Form:       8-K
Filed at:   2025-09-26T23:59:59+00:00
Accession:  0001437749-25-029951
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Reviva Pharmaceuticals reduces stockholder meeting quorum to 33⅓% of voting power
--------------------------------------------------------------------------------

- Board adopted quorum reduction from majority to one-third (33⅓%) of outstanding voting stock.
- Amendment effective September 26, 2025; applies to all stockholder meetings unless law or charter requires higher.
- Previous Bylaws required a majority of shares entitled to vote in person or by proxy.
- No other changes to the Bylaws were made.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1742927/000143774925029951/0001437749-25-029951-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1742927/000143774925029951/rvph20250925_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-029951

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer